Evidence map›Paper›PMID 26233957›Full record

ArticleAging2015

Removal of growth hormone receptor (GHR) in muscle of male mice replicates some of the health benefits seen in global GHR-/- mice.

Edward O List, Darlene E Berryman, Yuji Ikeno, Gene B Hubbard, Kevin Funk, Ross Comisford, Jonathan A Young, Michael B Stout, Tamar Tchkonia, Michal M Masternak and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Growth hormone receptor in VGLUT2 or Sim1 cells regulates glycemia and insulin sensitivity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Review
  5. Growth hormone receptor gene disruption.Vitamins and hormones · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Musculoskeletal Effects of Altered GH Action.Frontiers in physiology · 2022
    Review
  12. Article
  13. Article
  14. Mouse models of growth hormone insensitivity.Reviews in endocrine & metabolic disorders · 2021
    Review
  15. Growth hormone and aging.Reviews in endocrine & metabolic disorders · 2021
    Review
  16. Effect of growth hormone on insulin signaling.Molecular and cellular endocrinology · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Edward O List
Darlene E Berryman
Yuji Ikeno
Gene B Hubbard
Kevin Funk
Ross Comisford
Jonathan A Young
Michael B Stout
Tamar Tchkonia
Michal M Masternak
Andrzej Bartke
James L Kirkland
Richard A Miller
John J Kopchick
Biotechnology Institute · USMayo Clinic in Florida · USLongevity Biotech (United States) · USOhio University · USSouthern Illinois University School of Medicine · USUniversity of Central Florida · USUniversity of Michigan–Ann Arbor · US

Funding

TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI PETER J HORNSBY · 1995 to 2026
$30.6M
Research Education CoreP30AG024824 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Neil Alexander · 2004 to 2026
$29.2M
Systems Biology and Bioinformatics CoreP01AG041122 · NIA · MAYO CLINIC ROCHESTER · PI CAMPISI, JUDITH · 2012 to 2016
$9.8M
The Somatotropic Axis and Health Aging: A Search for MechanismsP01AG031736 · NIA · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI KIRKLAND, JAMES L. · 2009 to 2013
$8.4M
Longevity genes and calorie restriction: early post-natal effectsR01AG019899 · NIA · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI BARTKE, ANDRZEJ · 2001 to 2016
$6.1M
Dietary fat, visceral fat depots and agingR01AG032290 · NIA · UNIVERSITY OF CENTRAL FLORIDA · PI MASTERNAK, MICHAL MATEUSZ · 2010 to 2014
$1.5M
NIA NIH HHS AG032290NIA NIH HHS AG13319NIA NIH HHS P01 AG031736NIA NIH HHS P01AG031736NIA NIH HHS P01 AG041122NIA NIH HHS P30 AG013319NIA NIH HHS P30 AG024824NIA NIH HHS R01 AG019899NIA NIH HHS R01 AG032290
6 · The paper itself

Abstract

Global disruption of the GH receptor in mice (GHR-/-) produces a large and reproducible extension in lifespan. Since lack of GH action in muscle resulting in improved glucose homeostasis is potentially a mechanism by which GHR-/- mice are long-lived, and since no information on muscle-specific GHR disruption in females is available, we generated and characterized a line of muscle-specific GHR disrupted (MuGHRKO) mice. As expected, male MuGHRKO mice had improved fasting blood glucose, insulin, c-peptide, and glucose tolerance. In contrast, female MuGHRKO mice exhibited normal glucose, insulin, and glucose tolerance. Body weight was mildly but significantly altered in opposite directions in males (decreased) and females (increased) compared to controls. Grip strength and treadmill endurance were unchanged with advanced age in both sexes, suggesting that the direct action of GH on muscle has minimal effect on age-related musculoskeletal frailty. Longevity was unchanged in both sexes at Ohio University and significantly increased for males at University of Michigan. These data suggest that removal of GHR in muscle of male MuGHRKO mice replicates some of the health benefits seen in global GHR-/- mice including improvements to glucose homeostasis and smaller body weight in males, which may explain the trends observed in lifespan.

Indexed as

AnimalsBlood GlucoseBody CompositionBody WeightCarrier ProteinsC-PeptideEnergy MetabolismFemaleGlucose IntoleranceHealth StatusInsulinLongevityMaleMiceMice, KnockoutMuscle, SkeletalBlood GlucoseCarrier ProteinsC-PeptideInsulinsomatotropin-binding protein

Identifiers

PMID26233957
PMCPMC4543039
OpenAlexW2324996294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.